Better Buy: Eli Lilly vs. Novo Nordisk
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) recently reported their second-quarter financial results. All eyes were…
Better Buy: Eli Lilly vs. Novo Nordisk
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) recently reported their second-quarter financial results. All eyes were…
Pfizer’s Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound
The past few years have been rough on Pfizer (NYSE: PFE). The company has generally posted subpar financial…
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
Novo Nordisk A/S First GLP-1 pill approved in the European Union for the treatment of obesity and overweight…
Wegovy Pill in Europe – Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The…
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity
Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide…
Novo secures European approval for oral Wegovy to extend lead over Lilly
Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for…
NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish Counterpart
The European Commission also approved a convenient single-dose pen for the higher 7.2 mg injectable dose of Wegovy.…
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
Novo Nordisk A/S First GLP-1 pill approved in the European Union for the treatment of obesity and overweight…
Novo Nordisk signs pact to assess semaglutide implant
Novo Nordisk, the owner of the Ozempic and Wegovy GLP-1 drugs, has announced a deal to work with…
Novo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide Implant
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…